Get more replies from employers
Send a job-specific resume in minutes.
The FDA in Silver Spring offers a research fellowship in the Office of Vaccines Research and Review to explore how antibodies recognize viral proteins at the atomic level using cryo-EM.
You will learn protein expression/purification, cryo-EM data collection, and contribute to manuscript writing under mentorship, with a focus on enabling vaccine design.
The appointment is full-time for one year, starting in 2026, with a monthly stipend commensurate with education and experience.
U.S. Food and Drug Administration (FDA)
FDA-CBER-2026-0037
A research opportunity is currently available in the Office of Vaccines Research and Review (OVRR) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
You will join a new lab that uses cryo‑electron microscopy to understand how viral proteins are recognized by antibodies at an atomic level, and how that recognition can be exploited to design effective vaccines. You will learn to design and execute experiments to determine the structures of clinically relevant viral proteins and their associated antibodies and receptors. This is an exciting opportunity for those who want to learn structural biology and apply new ideas to antigen design.
Under the guidance of a mentor, you will learn how to:
The mentor for this opportunity is Jason Gorman (Jason.Gorman@fda.hhs.gov). If you have questions about the nature of the research, please contact the mentor.
2026; start date is flexible and will depend on a variety of factors.
The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.
The appointment is full-time.
The participant will receive a monthly stipend commensurate with educational level and experience.
This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non‑U.S. citizen applicants should refer to the Guidelines for Non‑U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.
Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment‑related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on‑boarded at FDA. OPM can complete a background investigation only for individuals, including non‑US Citizens, who have resided in the US for a total of three of the past five years.
If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
The qualified candidate should have received a master's or doctoral degree in one of the relevant fields (e.g. Structural Biology, Virology, Immunology, Biochemistry) or be currently pursuing the degree with completion expected prior to the appointment starting date. Degree must have been received within the past five years.
A background in protein expression, purification, and structural biology is preferred but drive, initiative, and an enthusiastic attitude can go a long way towards making up for a lack of experience.
Ashley